Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADL5859 in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ADL5859 in diabetic peripheral neuropathy (DPN), sponsored by Merck & Co.. Started Nov 2007; status: completed.
02
Drugs
ADL5859
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00603265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603265.